Schizophrenia and the Efficacy of qEEG-Guided Neurofeedback Treatment: A Clinical Case Series
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Schizophrenia is sometimes considered one of the most devastating of mental illnesses because its onset is early in a patient’s life and its symptoms can be destructive to the patient, the family, and friends. Schizophrenia affects 1 in 100 people at some point during their lives, and while there is no cure, it is treatable with antipsychotic medications. According to the Clinical Antipsychotic Trials for Interventions Effectiveness (CATIE), about 74% of the patients who have discontinued the first medication prescribed within a year will have a relapse afterward. This shows an enormous need for developing better treatment methods and better ways to manage the disease, since current therapies do not have sufficient impact on negative symptoms, cognitive dysfunction, and compliance to treatment. In this clinical case series, we investigate the efficacy of quantitative electroencephalography (qEEG)-guided neurofeedback (NF) treatment in this population, and whether this method has an effect on concurrent medical treatment and on the patients. Fifty-one participants (25 males and 26 females) ranging from 17 to 54 years of age (mean: 28.82 years and SD: 7.94 years) were included. Signed consent was received from all patients. Most of the participants were previously diagnosed with chronic schizophrenia, and their symptoms did not improve with medication. All 51 patients were evaluated using qEEG, which was recorded at baseline and following treatment. Before recording the qEEG, participants were washed out for up to 7 half-lives of the medication. After Food and Drug Administration (FDA)-approved Nx-Link Neurometric analysis, qEEGs suggested a diagnosis of chronic schizophrenia for all participants. This was consistent with the clinical judgment of the authors. The participants’ symptoms were assessed by means of the Positive and Negative Syndrome Scale (PANSS). Besides the PANSS, 33 out of 51 participants were also evaluated by the Minnesota Multiphasic Personality Inventory (MMPI) and the Test of Variables of Attention (TOVA), both at baseline and following treatment. Each participant was prescribed an NF treatment protocol based on the results of their qEEG neurometric analysis. Each session was 60 minutes in duration, with 1 to 2 sessions per day. When 2 sessions were administered during a single day, a 30-minute rest was given between the sessions. Changes in the PANSS, MMPI, and TOVA were analyzed to evaluate the effectiveness of NF treatment. The mean number of sessions completed by the participants was 58.5 sessions within 24 to 91 days. Three dropped out of treatment between 30 and 40 sessions of NF, and one did not show any response. Of the remaining 48 participants 47 showed clinical improvement after NF treatment, based on changes in their PANSS scores. The participants who were able to take the MMPI and the TOVA showed significant improvements in these measures as well. Forty were followed up for more than 22 months, 2 for 1 year, 1 for 9 months, and 3 for between 1 and 3 months after completion of NF. Overall NF was shown to be effective. This study provides the first evidence for positive effects of NF in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
The molecular biology of memory storage: a dialogue between genes and synapses
Kandel, E. R. (2001) · Science · doi:10.1126/science.1067020 · Cited by 3,917
The Emotional Brain, Fear, and the Amygdala
LeDoux, J. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1025048802629 · Cited by 1,818
Phelps, E. A., Delgado, M. R., Nearing, K. I., & LeDoux, J. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.042 · Cited by 1,753
Arns, M., de Ridder, S., Strehl, U., Breteler, M., & Coenen, A. (2009) · Clinical EEG and Neuroscience · doi:10.1177/155005940904000311 · Cited by 794
Lawrie, S. M., Buechel, C., Whalley, H. C., Frith, C. D., Friston, K. J., & Johnstone, E. C. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01316-1 · Cited by 529
Rosenkranz, J. A., Moore, H., & Grace, A. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11054.2003 · Cited by 344
Dysregulation of Arousal and Amygdala-Prefrontal Systems in Paranoid Schizophrenia
Williams, L. M., Das, P., Harris, A. W. F., Liddell, B. B., Brammer, M. J., Olivieri, G., Skerrett, D., Phillips, M. L., David, A. S., Peduto, A., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.480 · Cited by 337
Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study
Burns, J., Job, D., Bastin, M. E., Whalley, H., Macgillivray, T., Johnstone, E. C., & Lawrie, S. M. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.5.439 · Cited by 327
The effects of alpha/theta neurofeedback on personality and mood
Raymond, J., Varney, C., Parkinson, L. A., & Gruzelier, J. H. (2005) · Cognitive Brain Research · doi:10.1016/j.cogbrainres.2004.10.023 · Cited by 191
Cited by
Marzbani, H., Marateb, H., & Mansourian, M. (2016) · Basic and Clinical Neuroscience Journal · doi:10.15412/j.bcn.03070208 · Cited by 484
What is Neurofeedback: An Update
Hammond, D. C. (2011) · Journal of Neurotherapy · doi:10.1080/10874208.2011.623090 · Cited by 307
Time course of clinical change following neurofeedback
Rance, M., Walsh, C., Sukhodolsky, D. G., Pittman, B., Qiu, M., Kichuk, S. A., Wasylink, S., Koller, W. N., Bloch, M., Gruner, P., et al. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.05.001 · Cited by 124
Micoulaud-Franchi, J.-A., McGonigal, A., Lopez, R., Daudet, C., Kotwas, I., & Bartolomei, F. (2015) · Neurophysiologie Clinique/Clinical Neurophysiology · doi:10.1016/j.neucli.2015.10.077 · Cited by 111
Review of the therapeutic neurofeedback method using electroencephalography: EEG Neurofeedback
Omejc, N., Rojc, B., Battaglini, P. P., & Marusic, U. (2018) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2018.3785 · Cited by 91
Metadata
- Authors
- Surmeli, T., Ertem, A., Eralp, E., & Kos, I. H.
- Venue
- Clinical EEG and Neuroscience
- Publisher
- SAGE Publications
- Published
- 2012-03-27
- Volume
- 43
- Issue
- 2
- Pages
- 133-144
- ISSN
- 1550-0594 (ISSN-L)
- 2169-5202
- OpenAlex
- W2079535061
- Cited by
- 90
- References
- 10
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Schizophrenia and the Efficacy of qEEG-Guided Neurofeedback Treatment: A Clinical Case Series. https://app.cochat.ai/papers/10.1177/1550059411429531
- The paper
- Surmeli, T., Ertem, A., Eralp, E., & Kos, I. H. (2012). Schizophrenia and the Efficacy of qEEG-Guided Neurofeedback Treatment: A Clinical Case Series. Clinical EEG and Neuroscience. https://doi.org/10.1177/1550059411429531
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.